Zobrazeno 1 - 10
of 53
pro vyhledávání: '"P W, Kamphuisen"'
Autor:
Fleur H.J. Kaptein, Noori A.M. Guman, Susan B. Lohle, Frederikus A. Klok, Albert T.A. Mairuhu, Pieter W. Kamphuisen, Nick Van Es, Menno V. Huisman
Publikováno v:
TH Open, Vol 08, Iss 01, Pp e61-e71 (2024)
Background Current guidelines recommend either low-molecular weight heparin (LMWH) or direct oral anticoagulants (DOACs) as first-line treatment in cancer-associated venous thromboembolism (VTE).
Externí odkaz:
https://doaj.org/article/f85140c04041460d81f04682683bc4ae
Autor:
Eva N. Hamulyák, Hanke M. G. Wiegers, Luuk J. J. Scheres, Barbara A. Hutten, Maria E. deLange, Anne Timmermans, Peter E. Westerweel, Marten R. Nijziel, Marieke J. H. A. Kruip, Marije ten Wolde, Paula F. Ypma, Frederikus A. Klok, Laurens Nieuwenhuizen, Sanne vanWissen, Marcel M. C. Hovens, Laura M. Faber, Pieter W. Kamphuisen, Harry R. Büller, Saskia Middeldorp
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 1, Pp 223-230 (2021)
Abstract Background In premenopausal women, treatment with direct oral factor Xa inhibitors is associated with an increased risk of heavy menstrual bleeding (HMB) compared with vitamin K antagonists (VKA). Treatment with the direct oral thrombin inhi
Externí odkaz:
https://doaj.org/article/d2e8081b5c8c4589a7801e028e0b3c62
Autor:
Noémie Kraaijpoel, Frits I. Mulder, Marc Carrier, Annabel van Lieshout, Tom Würdinger, Myron G. Best, Bart J.M. van Vlijmen, Yassene Mohammed, Luis Jara-Palomares, Pieter W. Kamphuisen, Marcello Di Nisio, Walter Ageno, Jan Beyer-Westendorf, Thomas Vanassche, Frederikus A. Klokm, Hans-Martin Otten, Mike J.L. Peters, Benilde Cosmi, Marije ten Wolde, Patrick M.M. Bossuyt, Harry R. Büller, Nick van Es
Publikováno v:
Thrombosis Update, Vol 2, Iss , Pp 100030- (2021)
Occult cancer is detected in about 5% of patients with unprovoked venous thromboembolism (VTE) in the 12 months following VTE diagnosis. Current guidance suggests conducting a ‘limited’ cancer screening in these patients, consisting of medical hi
Externí odkaz:
https://doaj.org/article/2dd9496a84fc4b7081e92959d00b7e2f
Autor:
Frits I. Mulder, Matteo Candeloro, Pieter W. Kamphuisen, Marcello Di Nisio, Patrick M. Bossuyt, Noori Guman, Kirsten Smit, Harry R. Büller, Nick van Es
Publikováno v:
Haematologica, Vol 104, Iss 6 (2019)
We aimed to evaluate the performance of the Khorana score in predicting venous thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were searched from January 2008 to June 2018 for studies which evaluated the Khorana score. Two aut
Externí odkaz:
https://doaj.org/article/d4493cafff344f108fe9e1dadfc67536
Autor:
Christina L. Fanola, Christian T. Ruff, Sabina A. Murphy, James Jin, Anil Duggal, Noe A. Babilonia, Piyamitr Sritara, Michele F. Mercuri, Pieter W. Kamphuisen, Elliott M. Antman, Eugene Braunwald, Robert P. Giugliano
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 16 (2018)
Background Anticoagulation in patients with malignancy and atrial fibrillation is challenging because of enhanced risks for thrombosis and bleeding and the frequent need for invasive procedures. Data on direct oral antagonists in such patients are sp
Externí odkaz:
https://doaj.org/article/f40296bded45487d9e72511c1fa75950
Autor:
Nick van Es, Marcello Di Nisio, Gabriela Cesarman, Ankie Kleinjan, Hans-Martin Otten, Isabelle Mahé, Ineke T. Wilts, Desirée C. Twint, Ettore Porreca, Oscar Arrieta, Alain Stépanian, Kirsten Smit, Michele De Tursi, Suzanne M. Bleker, Patrick M. Bossuyt, Rienk Nieuwland, Pieter W. Kamphuisen, Harry R. Büller
Publikováno v:
Haematologica, Vol 102, Iss 9 (2017)
In ambulatory patients with solid cancer, routine thromboprophylaxis to prevent venous thromboembolism is not recommended. Several risk prediction scores to identify cancer patients at high risk of venous thromboembolism have been proposed, but their
Externí odkaz:
https://doaj.org/article/77d002a752324e66b38d01ca68793735
Publikováno v:
Frontiers in Physiology, Vol 4 (2013)
Background: A sympathetic shift in heart rate variability (HRV) from high, beat-to-beat, to lower frequencies may be an early signal of deterioration in a monitored patient. Most chronic heart failure (CHF) patients receive ß-blockers. This tends to
Externí odkaz:
https://doaj.org/article/5632cd8f086e471bbeecb0d040d4b6f0
Autor:
Renée A. Douma, Melanie Tan, Roger E.G. Schutgens, Shannon M. Bates, Arnaud Perrier, Cristina Legnani, Douwe H. Biesma, Jeffrey S. Ginsberg, Henri Bounameaux, Gualtiero Palareti, Marc Carrier, Gerben C. Mol, Grégoire Le Gal, Pieter W. Kamphuisen, Marc Righini
Publikováno v:
Haematologica, Vol 97, Iss 10 (2012)
Background D-dimer testing to rule out deep vein thrombosis is less useful in older patients because of a lower specificity. An age-adjusted D-dimer cut-off value increased the proportion of older patients (>50 years) in whom pulmonary embolism could
Externí odkaz:
https://doaj.org/article/79eefa355d0d4714b0af0a3366035268
Autor:
Bas van den Bogaard, Olav R. de Peuter, Berend E. Westerhof, Hendrik Best, Jasper Truijen, Pieter W. Kamphuisen, Bert-Jan H. van den Born
Publikováno v:
Artery Research, Vol 5, Iss 3 (2011)
Externí odkaz:
https://doaj.org/article/dd14d162dc5f4fd2bc9892f8d669f065
Autor:
Geerte L Van Sluis, Max Nieuwdorp, Pieter W Kamphuisen, Johan van der Vlag, Cornelis J F Van Noorden, C Arnold Spek
Publikováno v:
PLoS ONE, Vol 5, Iss 6, p e11200 (2010)
BACKGROUND: Some low molecular weight heparins (LMWHs) prolong survival of cancer patients and inhibit experimental metastasis. The underlying mechanisms are still not clear but it has been suggested that LMWHs (at least in part) limit metastasis by
Externí odkaz:
https://doaj.org/article/2b1587149b51485f913e80e54dead3da